ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,633Medicare Part D Prescriptions Filled, Including Refills

Rank: 610 out of 3647

$519K Total Retail Price of All Prescriptions

Rank: 1042 out of 3647

506 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
43% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 506 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

7% of this provider’s 506 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

2% of this provider’s 10,973 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$41 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
SIMVASTATIN 972 873 1 1
CRESTOR 537 464 2 19
ALENDRONATE SODIUM 502 463 3 23
OMEPRAZOLE 463 402 4 3
METFORMIN HCL 409 343 5 6
ALPRAZOLAM 339 270 6 31
METOPROLOL TARTRATE 303 268 7 7
AMLODIPINE BESYLATE 300 283 8 2
BENAZEPRIL-HYDROCHLOROTHIAZIDE 290 283 9 270
NAPROXEN 274 253 10 70
LEVOTHYROXINE SODIUM 243 232 11 5
FENOFIBRATE 241 202 12 50
LISINOPRIL 236 201 13 4
BENAZEPRIL HCL 223 209 14 71
ATENOLOL 222 183 15 10
HYDROCHLOROTHIAZIDE 219 175 16 9
VIAGRA 212 168 17 69
GLIPIZIDE 183 158 18 41
ATORVASTATIN CALCIUM 183 170 18 13
CLONIDINE HCL 177 166 20 46
LORAZEPAM 167 144 21 73
FUROSEMIDE 163 147 22 8
ZOLPIDEM TARTRATE 158 131 23 14
IBUPROFEN 157 112 24 55
LOVAZA 150 138 25 117
NEXIUM 141 104 26 44
ALLOPURINOL 140 129 27 37
GLYBURIDE 124 114 R 28 54
GABAPENTIN 119 105 29 17
MEGESTROL ACETATE 116 114 R 30 138
RANITIDINE HCL 116 105 30 29
TRICOR 107 90 32 144
DICLOFENAC SODIUM 103 78 33 86
CLOTRIMAZOLE-BETAMETHASONE 99 88 34 84
FLUTICASONE PROPIONATE 98 93 35 32
AZITHROMYCIN 96 84 36 34
ADVAIR DISKUS 93 84 37 52
TEMAZEPAM 88 55 38 47
METOPROLOL SUCCINATE 86 84 39 18
WARFARIN SODIUM 84 84 40 15
NIFEDIPINE ER 82 77 41 67
PREDNISONE 79 75 42 43
TAMSULOSIN HCL 79 74 42 28
LOVASTATIN 75 69 44 21
DIOVAN 75 71 44 40
DONEPEZIL HCL 73 73 46 30
MECLIZINE HCL 67 60 47 85
ACETAMINOPHEN-CODEINE 67 42 S3 47 149
ENALAPRIL MALEATE 66 60 49 35
LISINOPRIL-HYDROCHLOROTHIAZIDE 64 52 50 36
CARVEDILOL 63 63 51 20
PANTOPRAZOLE SODIUM 63 48 51 38
CLOPIDOGREL 55 43 53 26
CAPTOPRIL 54 50 54 193
METHYLPREDNISOLONE 54 49 54 78
PROAIR HFA 53 34 56 62
PAROXETINE HCL 50 29 57 60
SYNTHROID 50 50 57 42
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 28, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.